How can the NHS deliver patient centric care?
‘Patient centricity’, the process of designing a service or solution around a patient’s wants, needs and preferences, is a key aspiration for the NHS....
Working together: NHS and pharma in diabetes
Neil MacDonald, Area Healthcare Lead for MSD in North and East Scotland, on the Pf Award-winning real time data-led joint working project involving the Scottish...
Driving patient centricity in patient-facing programmes
How one company created a core proposition which puts the patient first in all the work it does. All companies within the healthcare sector...
Using big data in healthcare
Does big data deliver on its promises – and what does the patient really think? Over the past 20 years, big data has exploded with...
Creating patient centric ways of working
How can industry move from words to action to create truly patient centric ways of working? For over a decade, biopharma has been talking about the...
Telling our people to be patient focused: Our biggest mistake in pharma?
How can pharmaceutical companies bring patient centricity to life for their people? What’s one of the biggest mistakes we’re making in pharma? We’re telling our...
Averting the crisis in general practice through collaboration
Chris Barker, Chief Executive of the Spirit Health Group, explores how to avert the crisis in general practice through collaboration. He believes a new...
Six steps to key account management in pharma
David Southern and Gary Lunt outline six steps to key account management in pharma to enable the sector to adapt to complex and ever-changing...
The art of customer experience management (CXM)
Magnus Franzen explains why customer experience management is essential to delivering what your customers need. Customer experience management (CXM) is both a discipline and a philosophy.
“ACROSS...
Transition and transformation in the pharmaceutical industry
Ben Osborn, Managing Director of Pfizer UK, talks transition and transformation in the pharmaceutical industry. Ben Osborn is the recently appointed Managing Director of Pfizer...
Latest articles
Drug firms admit to colluding to keep up prices of antidepressants
Drug firms admit to colluding in order to keep up prices of antidepressants according to the Competition and Markets Authority (CMA). Two suppliers of the...
Licensing status of Avastin updated by MHRA
The licensing status of Avastin has been updated by the Medicines and Healthcare products Regulatory Agency (MHRA). The update concerns the licensing status of Avastin (bevacizumab)...
PM Society Digital Award Winners 2019
Thursday 19th September saw the tenth PM Society Digital Awards take place at The Brewery in London. Around 500 guests sat down to dinner...
Popular articles
Nurofen launches a 24 hour ibuprofen pain relief patch
Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen. Despite body pain being among the most commonly...
Licensing status of Avastin updated by MHRA
The licensing status of Avastin has been updated by the Medicines and Healthcare products Regulatory Agency (MHRA). The update concerns the licensing status of Avastin (bevacizumab)...
PM Society Digital Award Winners 2019
Thursday 19th September saw the tenth PM Society Digital Awards take place at The Brewery in London. Around 500 guests sat down to dinner...
Poor diabetes control costs the NHS £3bn in avoidable treatment
New research finds that poor diabetes control costs the NHS £3bn in potentially avoidable hospital treatment in England. The findings, being presented at this year’s...
Drug firms admit to colluding to keep up prices of antidepressants
Drug firms admit to colluding in order to keep up prices of antidepressants according to the Competition and Markets Authority (CMA). Two suppliers of the...